Browse > Article

IMMUNOHISTOCHEMICAL STUDY ON EXPRESSION OF MMP-2 AND MMP-9 IN IRRITATION FIBROMA, ORAL LEUKOPLAKIA AND ORAL SQUAMOUS CELL CARCINOMA  

Kim, Moon-Key (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University)
Lee, Eun-Ha (Department of Oral Pathology, College of Dentistry, Yonsei University)
Kim, Jin (Department of Oral Pathology, College of Dentistry, Yonsei University)
Lee, Eui-Woong (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University)
Cha, In-Ho (Department of Oral and Maxillofacial Surgery, College of Dentistry, Yonsei University)
Publication Information
Journal of the Korean Association of Oral and Maxillofacial Surgeons / v.32, no.4, 2006 , pp. 352-359 More about this Journal
Abstract
MMP-2 and MMP-9, type IV collagenases which degrade basement membrane, have been known to play important roles in invasion and metastasis of tumor cells, In addition, they seem to be involved in cell differentiation, apoptosis, angiogenesis and immunity, etc. We immunohistochemically examined epithelial and stromal expressions of MMP-2 and MMP-9 in irritation fibroma, oral leukoplakia, and oral squamous cell carcinoma (OSCC) and have some results as follows: 1. Irritation fibromas, oral leukoplakias and OSCCs mostly showed increased expression of MMP-2 and MMP-9 in the epithelium and connective tissue compared with normal mucosa. 2. There was a significant difference in the epithelial expression of MMP-2 and MMP-9 between irritation fibroma and oral leukoplakia. 3. There was a significant difference in the epithelial and stromal expression of MMP-2 and MMP-9 between irritation fibroma and OSCC. 4. There was a significant difference in the stromal expression of MMP-9 between oral leukoplakia and OSCC. We concluded that rritation fibroma, oral leukoplakia and OSCC have somewhat different characteristics of MMP-2 and MMP-9 expressions, which perhaps result from different pathogenesis.
Keywords
Citations & Related Records
연도 인용수 순위
  • Reference
1 Parks WC & Mecham RP: Matrix metalloproteinases, San Diego, Academic Press, 1998
2 Veli-Matti K & Saarialho-Kere U: Matrix metalloproteinases and their inhibitors in tumour growth and invasion. Ann Med 1999;31:34- 45   DOI   ScienceOn
3 Balducci C, Lilli C, Stabellini G, Marinucci L, Giustozzi G, Becchetti A, Cagini L, Locc P: Human desmoid fibroblasts: matrix metalloproteinases, their inhibitors and modulation by Toremifene. BMC Cancer 2005;5:22-35   DOI   ScienceOn
4 Desmouliere A, Guyot C, Gabbiani G: The stroma reaction myofibroblast: a key player in the control of tumor cell behavior. Int J Dev Biol 2004;48:509-517   DOI   ScienceOn
5 Reibel J: Prognosis of oral pre-malignant lesions: Significance of clinical, histopathological, and molecular biological characteristics. Crit Rev Oral Biol Med 2003;14(1):47-62   DOI
6 Werner JA, Rathcke IO, Mandic R: The role of matrix metalloproteinases in squamous cell carcinomas of the head and neck. Clin Exp Metastasis 2002;19:275-282   DOI
7 Kurahara S, Shinohara M, Ikebe T, Nakamura S, Beppu M, Hiraki A, Takeuchi H, Shirasuna K: Expression of MMPs, MT-MMP, and TIMPs in squamous cell carcinoma of the oral cavity: correlations with tumor invasion and metastasis. Head Neck 1999;21(7):627-638   DOI   ScienceOn
8 Heppner KJ, Matrisian LM, Jensen RA, Rodgers WH: Expressino of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response. Am J Pathol 1996;149(1):273- 282
9 Duffy MJ, Maguire TM, Hill A, McDermott E, O'Higgins N: Metalloproteinases: role in breast carcinogenesis, invasion and metastasis. Breast Cancer Res 2000;2(4):252-257   DOI
10 Batsakis JG: Clinical pathology of oral cancer. In Shah JP, Johnson NW, Batsakis JG : Oral Cancer, London, Martin Dunitz, 2003
11 Petruzzelli GJ: The biology of distant metastases in head and neck cancer. ORL 2001;63:192-201   DOI   ScienceOn
12 Liotta LA: Tumor invasion and metastases - role of extracellular matrix. Cancer Res 1986;46(1):1-7   DOI
13 Charous SJ, Stricklin GP, Nanney LB, Netterville JL, Burkey BB: Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngol 1997;106(4):271-278   DOI
14 Liabakk NB, Talbot I, Smith RA, Wilkinson K, Balkwill F: Matrix metalloproteinase 2 (MMP-2) and matrix metalloproteinase (MMP-9) type IV collagenases in colorectal cancer. Cancer Res 1996; 56(1):190-196
15 Rocca G, Pucci-Minafra I, Marrazo A, Taormina P, Minafra S: Zymographic detection and clinical correlations of MMP-2 and MMP-9 in breast cancer sera. Br J Cancer 2004;90(7):1414-1421   DOI   ScienceOn
16 Hong SD, Hong SP, Lee JI, Lim CY: Expression of matrix metalloproteinase- 2 and -9 in oral squamous cell carcinomas with regard to the metastatic potential. Oral Oncol 2000;36(2):207-213   DOI   ScienceOn
17 Liotta LA & Kohn EC: The microenvironment of the tumor-host interface. Nature 2001;411:375-379   DOI   ScienceOn
18 Lengyel E, Gum R, Juarez J, Clayman G, Seiki M, Sato H, Boyd D: Induction of M(r) 92,000 type IV collagenase expression in a squamous cell carcinoma cell line by fibroblasts. Cancer Res 1995;55(4):963-967
19 Van den Steen PE, Opdenakker G, Wormald MR, Dwek RA, Rudd PM: Matrix remodelling enzymes, the protease cascade and glycosylation. Biochim Biophys Acta 2001;1528:61-73   DOI
20 Regezi JA & Sciubba J: Oral Pathology: Clinical-Pathologic Correlations, 2nd ef. Philadelphia, W.B.Saunders, 1989, pp.202-204
21 Thomas GT, Lewis MP, Speight PM: Matrix metalloproteinases and oral cancer. Oral Oncol 1999;35:227-233   DOI   ScienceOn
22 Brown PD, Levy AT, Marglies IM, Liotta LA, Stetler-Stevenson WG: Independent expression and cellular processing of Mr 72,000 type IV collagenase and interstitial collagenase in human tumorigenic cell lines. Cancer Res 1990;50(19):6184-6191
23 Mook ORF, Frederiks WM, Van Noorden CJK: The role of gelatinases in colorectal cancer progression and metastasis. Biochim Biophy Acta. 2004;1705(2):69-89
24 McCawley LJ & Matrisian LM: Matrix metalloproteinases: they're not just for matrix anymore! Curr Opin Cell Biol 2001;13(5):534- 540   DOI   ScienceOn
25 Sudbo/ J: Novel management of oral cancer: A paradigm of predictive oncology. Clin Med Res 2004;2(4):233-242   DOI
26 Schmalfeldt B, Prechtel D, Harting K, Spathe K, Rutke S, Konik E, Fridman R, Berger U, Schmitt M, Kuhn W, Lengyel E: Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer. Clin Cancer Res 2001;7(8):2396-2404
27 Stamenkovic I: Extracelluler matrix remodelling: the role of matrix metalloproteinases. J Pathol 2003;200:448-464   DOI   ScienceOn
28 Nagpal JK & Das BR: Oral cancer: reviewing the present understanding of its molecular mechanism and exploring the future directions for its effective management. Oral Oncol 2003;39(3):213-21   DOI   ScienceOn
29 Shah JP & Patel SG: Cervical lymph node. In Shah JP & Patel SG: Head and Neck Surgery and Onoclogy, 3rd ed. London, Mosby, 2003, p53
30 Okada Y, Mataga I, Katagiri M, Ishii K: An analysis of cervical lymph nodes metastasis in oral squamous cell carcinoma. Relationship between grade of histopathological malignancy and lymph nodes metastasis. In J Oral Maxillofac Surg 2003;32(3):284- 288   DOI   ScienceOn
31 Goepfert H: Squamous cell carcinoma of the head and neck: past progress and futire promise. CA Cacner J Clin 1998;48(4):195-198   DOI   ScienceOn
32 Chambers AF & Matrisian LM: Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 1997;89:1260- 1270   DOI   ScienceOn
33 Shingaki S, Takada M, Sasai K, Bibi R, Kobayashi T, Nomura T, Saito C: Impact of lymph node metastasis on the pattern of failure and survival in oral carcinomas. Am J Surg 2003;185:278-284   DOI   ScienceOn
34 Hynes RO: Metastatic potential: generic predisposition of the primary tumor or rare metastatic variants or both? Cell 2003;113:821-823   DOI   ScienceOn
35 Lumerman H, Freedman P, Kerpel S: Oral epithelial dysplasia and the development of invasive squamous cell carcinoma. Oral Surg Oral Med Oral Pathol Oral Radiol Endoc 1995;79:321-329   DOI   ScienceOn
36 Eicher SA & Clayman GL: Pathophysiology of nodal metastasis and rationale for neck dissection. In Gluckman JL & Johnson JT : Surgical management of neck metastasis, London, Martin Dunitz, 2003, pp23-24
37 Woessner JF & Nagase H: Matrix Metalloproteinases and TIMPs, Oxford, Oxford University Press, 2000, pp1-10
38 Neville BW, Damm DD, Allen CM, Bouquot JE: Oral and Maxillifacial Pathology. Philadelphia, W.B. Saunders, 1995, p362
39 Passlick B, Sienel W, Seen-Hibler R, Wockel W, Thetter O, Mutschler W, Pantel K: Overexpression of matrix metalloproteinase 2 predicts unfavorable outcome in early-stage non-small cell lung cancer. Clin Cancer Res 2000;6(10):3944-3948
40 Davidson B, Goldberg I, Gotlieb WH, Kopolovic J, Ben-Baruch G, Nesland JM, Berner A, Bryne M, Reich R: High levels of MMP-2, MMP-9, MT1-MMP and TIMP-2 mRNA correlate with poor survival in ovarian carcinoma. Clin Exp Metastasis 1999;17(10):799-808   DOI
41 Edwards DR & Murphy G: Proteases - invasion and more. Nature 1998;394:527-528   DOI   ScienceOn
42 Spiro RH, Alfonso AE, Farr HW, Strong EW: Cervical node metastasis from epidermoid carcinoma of the oral cavity and oropharynx. A critical assessment of current staging. Am J Surg 1974;128(4):562- 567   DOI   ScienceOn
43 Powell WC, Matrisian LM: Complex roles of matrix metalloproteinases in tumor progression. In Gunthert U & Birchmeier W: Attempts to Understand Metastasis Formation I: Metastasis-Related Molecules, Berlin, Springer, 1996, pp1-21
44 Wood M, Fudge K, Mohler JL, Frost AR, Garcia F, Wang M, Stearns ME: In situ hybridization studies of metalloproteinases 2 and 9 and TIMP-1 and TIMP-2 expression in human prostate cancer. Clin Exp Metastasis 1997;15:246-258   DOI   ScienceOn